Efficacy of adding high-dose In-111 octreotide therapy during Sandostatin treatment in patients with disseminated neuroendocrine tumors: clinical results of 14 patients

ÖZKAN, ELGİN; Tokmak, Emel; KÜÇÜK, NURİYE

doi:10.1007/s12149-011-0482-2

Efficacy of adding high-dose In-111 octreotide therapy during Sandostatin treatment in patients with disseminated neuroendocrine tumors: clinical results of 14 patients

ÖZKAN E., Tokmak E., KÜÇÜK N. Ö.

ANNALS OF NUCLEAR MEDICINE, cilt.25, sa.6, ss.425-431, 2011 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 25 Sayı: 6
Basım Tarihi: 2011
Doi Numarası: 10.1007/s12149-011-0482-2
Dergi Adı: ANNALS OF NUCLEAR MEDICINE
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.425-431
Anahtar Kelimeler: In-111 octreotide, Neuroendocrine tumors, Sandostatin, Treatment response, METASTATIC CARCINOID-TUMOR, SOMATOSTATIN ANALOGS, GEP-TUMORS, CHEMOTHERAPY, INTERFERON, MANAGEMENT, 5-FLUOROURACIL, LOCALIZATION, DIAGNOSIS, SURVIVAL
Ankara Üniversitesi Adresli: Evet

Özet

This study aimed to assess the outcome of high-dose In-111 octreotide treatment and efficacy of long-acting Sandostatin LAR in patients with disseminated neuroendocrine tumors.